117 results
8-K
EX-99.1
NAOV
NanoVibronix Inc
9 Apr 24
NanoVibronix Issues Letter to Stockholders
4:05pm
and acceptable standard for pain relief and the avoidance of opioids.
Reimbursement
After four years, our efforts to obtain full approval for PainShield … them to reconsider. Our efforts to obtain CMS approval continue.
Reimbursement is currently approved in the Veterans’ Health System and several
8-K
EX-99.1
NAOV
NanoVibronix Inc
28 Mar 24
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
9:09am
, reimbursement, EU MDR compliance, and preclinical evidence faster through proven expertise and resources. Our comprehensive approach ensures that all key
8-K
EX-99.1
gd08euvucgbe735
14 Nov 23
NanoVibronix Issues Letter to Shareholders
12:00am
8-K
EX-99.1
gqv6lvhb
7 Nov 23
Receives Stocking Order from U.K. Distribution Partner in Anticipation of Increasing Demand
8:30am
8-K
EX-99.1
tto8i6rl6 ztn
27 Sep 23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:00am
424B3
texjb
21 Sep 23
Prospectus supplement
10:27am
8-K
EX-10.1
37haha6
1 Sep 23
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:30pm
8-K
EX-99.1
1chblx
28 Aug 23
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:30am
8-K
2jq1ec4
23 Aug 23
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
4:45pm
8-K
EX-99.1
wlv4hrifyoi8e0
23 Aug 23
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
4:45pm